Deutsche Bank
RCEL icon

Deutsche Bank’s Avita Medical RCEL Stock Holding History

Deutsche Bank’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Buy
31,732
+23,836
+302% +$100K ﹤0.01% 3207
2025
Q4 		$27.2K Buy
7,896
+7,352
+1,351% +$29.3K ﹤0.01% 3502
2025
Q3 		$2.78K Sell
544
-14,509
-96% -$75.7K ﹤0.01% 3554
2025
Q2 		$79.6K Sell
15,053
-4,648
-24% -$33.8K ﹤0.01% 3330
2025
Q1 		$160K Sell
19,701
-3,120
-14% -$29.2K ﹤0.01% 3049
2024
Q4 		$292K Buy
22,821
+10,063
+79% +$119K ﹤0.01% 2929
2024
Q3 		$137K Buy
12,758
+129
+1% +$1.21K ﹤0.01% 3110
2024
Q2 		$100K Sell
12,629
-2,626
-17% -$25K ﹤0.01% 3103
2024
Q1 		$245K Sell
15,255
-822
-5% -$13.3K ﹤0.01% 2729
2023
Q4 		$221K Buy
+16,077
New +$184K ﹤0.01% 2824
2023
Q3 		– Sell
-11,349
Closed -$193K – 3800
2023
Q2 		$193K Buy
+11,349
New +$167K ﹤0.01% 2895
2022
Q2 		– Sell
-14,131
Closed -$120K – 4286
2022
Q1 		$120K Sell
14,131
-1,558
-10% -$14.4K ﹤0.01% 3516
2021
Q4 		$188K Buy
15,689
+772
+5% +$11.8K ﹤0.01% 3417
2021
Q3 		$265K Sell
14,917
-201
-1% -$3.79K ﹤0.01% 3418
2021
Q2 		$310K Buy
+15,118
New +$298K ﹤0.01% 3525

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's RCEL Position: Q1 2026 in Review

Deutsche Bank increased its Avita Medical (RCEL) stake by 302% in Q1 2026, buying an estimated $100K and bringing the position to 31,732 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Deutsche Bank first reported a position in RCEL in Q2 2021 and has held it in 15 quarters since. The position peaked at $310K in Q2 2021. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Deutsche Bank held 31,732 shares of Avita Medical worth $117K as of Q1 2026.
  • Deutsche Bank bought 23,836 Avita Medical shares in Q1 2026, an estimated $100K.
  • Avita Medical made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3207 holding.
  • Deutsche Bank first reported a position in Avita Medical in Q2 2021 and has held it in 15 quarters since.
  • Deutsche Bank's Avita Medical position peaked at $310K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.